Temozolomide-Associated Liver Fibrosis.
Department of Medical Oncology, Austin Health, Melbourne, Victoria, Australia.|Olivia Newton-John Cancer Research Institute, , Austin Health, Melbourne, Victoria, Australia.|School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia.
Sagun
S
Parakh
Department of Medical Oncology, Austin Health, Melbourne, Victoria, Australia.
Anis
A
Hamid
Department of Medical Oncology, Austin Health, Melbourne, Victoria, Australia.
Lawrence
L
Cher
Department of Medical Oncology, Austin Health, Melbourne, Victoria, Australia. hui.gan@onjcri.org.au.|Olivia Newton-John Cancer Research Institute, , Austin Health, Melbourne, Victoria, Australia. hui.gan@onjcri.org.au.|School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia. hui.gan@onjcri.org.au.
Hui K
HK
Gan
D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects; D003606:Dacarbazine / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D008103:Liver Cirrhosis / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D000077204:Temozolomide
D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D000077204:Temozolomide